PassPort Technologies Interviewed by Japan's Nikkei Business Daily ( 日経産業新聞 )

November 18, 2019 -- PassPort Technologies was featured in a recent article published by Nikkei Business Daily. The interview was conducted with PassPort's COO, Dr. Hirotoshi Adachi -- 点滴や錠剤を「貼り薬OKに」 米企業が新投与技術

Hokkaido University and PassPort Technologies Initiate Joint Research to Develop Alzheimer's Drug

October 18, 2019 --  Expecting early clinical application of ground-breaking drug discovery innovation generated by Hokkaido University and administered by new drug delivery technology (PassPort® System)

PassPort Technologies Announces Collaboration with Axcelead Drug Discovery Partners

October 1, 2019 -- PassPort Technologies and Axcelead Drug Discovery Partners:

  • Enter a comprehensive  collaborative partnership in the field of drug discovery service using  PassPort® System, a new active transdermal drug delivery technology
  • Contribute to maximizing R&D pipeline value though providing a new modality

Nitto Denko Alliance with Drug Discovery Gateway Partnership to Commercialize the PassPort® System

July 1, 2019 -- Nitto Denko Corporation and the Drug Discovery  Gateway Investment Limited Partnership operated by  Whiz Partners Inc. entered an alliance to accelerate the  commercialization of the PassPort® System, an innovative transdermal therapeutic  system.